Thryv Therapeutics

Thryv Therapeutics Inc. is a Canadian clinical-stage biopharmaceutical company headquartered in Montreal, Quebec. The company specializes in discovering and developing innovative precision medicines for inherited cardiac arrhythmias, cardiometabolic diseases, and cardiomyopathies. Its primary research focus is the development of highly potent and s... elective inhibitors of serum and glucocorticoid-regulated kinase, a biological signaling pathway involved in electrical instability, inflammation, fibrosis, and structural remodeling. Through its drug discovery and development activities, Thryv Therapeutics aims to address significant unmet medical needs in cardiovascular medicine and improve treatment options for patients living with serious and potentially life-threatening conditions.Read More